{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T09:10:44Z","timestamp":1791882644751,"version":"4.3.4"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["T32CA09168"],"award-info":[{"award-number":["T32CA09168"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ypmed.2022.107157","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T08:11:55Z","timestamp":1657267915000},"page":"107157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screening"],"prefix":"10.1016","volume":"162","author":[{"given":"Philip E.","family":"Castle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Befano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schiffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Wentzensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Lorey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Poitras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Hyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li C.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2022.107157_bb0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/pgp.0b013e31805152ab","article-title":"CIN2 is a much less reproducible and less valid diagnosis than CIN3: results from a histological review of population-based cervical samples","volume":"26","author":"Carreon","year":"2007","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.ypmed.2022.107157_bb0010","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/archinternmed.2012.1744","article-title":"Safety against cervical precancer and cancer following negative human papillomavirus and Papanicolaou test results in human immunodeficiency virus-infected women","volume":"172","author":"Castle","year":"2012","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ypmed.2022.107157_bb0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.5858\/arpa.2019-0241-OA","article-title":"Relationships of p16 immunohistochemistry and other biomarkers with diagnoses of cervical abnormalities: implications for LAST terminology","volume":"144","author":"Castle","year":"2020","journal-title":"Arch. Pathol. Lab. Med."},{"key":"10.1016\/j.ypmed.2022.107157_bb0020","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1002\/sim.7380","article-title":"Mixture models for undiagnosed prevalent disease and interval-censored incident disease: applications to a cohort assembled from electronic health records","volume":"36","author":"Cheung","year":"2017","journal-title":"Stat. Med."},{"key":"10.1016\/j.ypmed.2022.107157_bb0025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1001\/jama.2018.10897","article-title":"Screening for cervical Cancer: US preventive services task force recommendation statement","volume":"320","author":"Curry","year":"2018","journal-title":"Jama"},{"key":"10.1016\/j.ypmed.2022.107157_bb0030","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/dju153","article-title":"Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test","volume":"106","author":"Gage","year":"2014","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ypmed.2022.107157_bb0035","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.ypmed.2022.107157_bib91","doi-asserted-by":"crossref","first-page":"e3572","DOI":"10.1093\/cid\/ciaa1391","article-title":"Primary care guidance for persons with human immunodeficiency virus: 2020 update by the HIV Medicine Association of the Infectious Diseases Society of America","volume":"73","author":"Thompson","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ypmed.2022.107157_bb0040","year":"2021"},{"key":"10.1016\/j.ypmed.2022.107157_bb0045","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1214\/17-AOAS1036","article-title":"Flexible risk prediction models for left or interval-censored data from electronic health records","volume":"11","author":"Hyun","year":"2017","journal-title":"Ann. Appl. Stat."},{"key":"10.1016\/j.ypmed.2022.107157_bb0050","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S1470-2045(11)70145-0","article-title":"Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice","volume":"12","author":"Katki","year":"2011","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ypmed.2022.107157_bb0055","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jama.2012.5664","article-title":"Risk of cervical precancer and cancer among HIV-infected women with normal cervical cytology and no evidence of oncogenic HPV infection","volume":"308","author":"Keller","year":"2012","journal-title":"Jama"},{"key":"10.1016\/j.ypmed.2022.107157_bb0060","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1093\/cid\/civ569","article-title":"Cervical precancer risk in HIV-infected women who test positive for oncogenic human papillomavirus despite a normal pap test","volume":"61","author":"Keller","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ypmed.2022.107157_bb0065","article-title":"Adverse obstetric outcomes after local treatment for cervical preinvasive and early invasive disease according to cone depth: systematic review and meta-analysis","volume":"354","author":"Kyrgiou","year":"2016","journal-title":"Bmj"},{"key":"10.1016\/j.ypmed.2022.107157_bb0070","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/LGT.0000000000000525","article-title":"2019 ASCCP risk-based management consensus guidelines for abnormal cervical cancer screening tests and cancer precursors","volume":"24","author":"Perkins","year":"2020","journal-title":"J. Low Genit. Tract. Dis."},{"key":"10.1016\/j.ypmed.2022.107157_bb0075","article-title":"Cumulative incidence of cancer among persons with HIV in North America: a cohort study","volume":"163:507=18","author":"Silverberg","year":"2015","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2022.107157_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30459-9","article-title":"Estimates of the global burden of cervical cancer associated with HIV","volume":"9","author":"Stelzle","year":"2021","journal-title":"Lancet Glob. Health"},{"key":"10.1016\/j.ypmed.2022.107157_bb0085","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.285.11.1500","article-title":"Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL triage study","volume":"285","author":"Stoler","year":"2001","journal-title":"Jama"},{"key":"10.1016\/j.ypmed.2022.107157_bb0090","article-title":"Clinical course of untreated cervical intraepithelial neoplasia grade 2 under active surveillance: systematic review and meta-analysis","volume":"360","author":"Tainio","year":"2018","journal-title":"Bmj"}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522002067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091743522002067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T15:07:01Z","timestamp":1777475221000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091743522002067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":19,"alternative-id":["S0091743522002067"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107157","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comparison of high-grade cervical abnormality risks in women living with and without human immunodeficiency virus undergoing routine cervical-cancer screening","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2022.107157","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107157"}}